Latest Updates & News

New Drug Shows Promise for Treating Advanced Endometrial Cancer

New Drug Shows Promise for Treating Advanced Endometrial Cancer

What Did the Research Discover? Researchers studied sacituzumab govitecan (SG) as a possible treatment for advanced endometrial cancer (EC) in patients who had already undergone chemotherapy and immunotherapy. The study was part of the TROPiCS-03 trial, which included patients with various metastatic solid tumors. In this phase II study, 41 patients with advanced EC...

COVID-19 and the Long-Term Risk of Autoimmune Disorders

COVID-19 and the Long-Term Risk of Autoimmune Disorders

What Did the Research Discover? Researchers investigated whether COVID-19 infection increases the long-term risk of developing autoimmune and autoinflammatory connective tissue disorders. The study included 6,912,427 participants in South Korea, with 3,145,388 individuals who had COVID-19 and 3,767,039 who did not. The participants were followed for at least 180...

FDA New Update: New Treatments, Safety Alerts, and Medical Advancements

FDA New Update: New Treatments, Safety Alerts, and Medical Advancements

For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation...